Do Low High Density Lipoprotein (HDL) Levels Predict Treatment Outcome in Patients With Chronic Hepatitis C Viral Infection?
The working hypothesis is that the low HDL serum level predict favorable response to anti viral treatment in chronic HCV (genotype 1) viral infection. This might be used to improve the rate of sustained virologic response.
|Study Design:||Time Perspective: Prospective|
|Official Title:||Do Low HDL Levels Predict Treatment Outcome in Patients With Chronic Hepatitis C Viral Infection?|
- sustained viral response [ Time Frame: 72 weeks ] [ Designated as safety issue: No ]achieving SVR
|Study Start Date:||April 2008|
|Study Completion Date:||January 2009|
|Primary Completion Date:||October 2008 (Final data collection date for primary outcome measure)|
Other: Non Responders
Lipoproteins are closely connected to the process of hepatitis C virus (HCV) infection. Metabolic syndrome predicts negative treatment outcome in HCV infection.
Aim: to assess the association between lipids components of the metabolic syndrome and sustained viral response (SVR).
Please refer to this study by its ClinicalTrials.gov identifier: NCT01159613
|Ziv medical center liver unit|
|Safed, Israel, Israel|